As of February 2022, the pharmaceutical company, GSK, in India saw the highest revenue from its anti-infective Augmentin drug sales, amounting to above six billion Indian rupees. Comparatively, Infanrix Hexa generated a revenue of over 1.2 billion Indian rupees. GlaxoSmithKline Pharmaceuticals India produces drugs for various therapies such as derma, hormones, vaccines, and analgesics.
Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India
Market overview
6
- Premium Statistic Revenue of the OTC pharmaceuticals in selected countries worldwide
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2024
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Share of pharmacy in organized retail India FY 2020-2022
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
GSK India - key figures
6
- Premium Statistic GSK's revenue by region 2013-2023
- Premium Statistic GSK's number of employees by region 2011-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
Product portfolio
3
Further Content: You might find this interesting as well
Motilal Oswal Group. (March 8, 2022). Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/
Motilal Oswal Group. "Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees)." Chart. March 8, 2022. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/
Motilal Oswal Group. (2022). Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/
Motilal Oswal Group. "Revenue of Gsk Pharmaceuticals India from Drug Sales as of February 2022, by Leading Drug (in Million Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/
Motilal Oswal Group, Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees) Statista, https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/ (last visited May 11, 2024)
Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1382599/gsk-pharmaceuticals-india-sales-by-leading-drug/